fulvestrant NDC 25021-471

NDC codes

FDA NDC Directory

Product NDC (as listed)25021-471Labeler and product segments. Claims need a package NDC.

Product NDC at billing width25021-0471Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
25021-471-74	25021047174	2 SYRINGE in 1 CARTON (25021-471-74) / 5 mL in 1 SYRINGEMarketed from Sep 15, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): fulvestrant
Generic name (nonproprietary): fulvestrant
Active ingredients: Fulvestrant — 50 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular
Labeler: Sagent Pharmaceuticals
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211422
Marketing start: Sep 15, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Estrogen Receptor Antagonists (Mechanism)Selective Estrogen Receptor Modulators (Mechanism)
Identifiers: Product ID 25021-471_09ecb935-fe1c-4e1f-9de0-cc7227c63768SPL ID 09ecb935-fe1c-4e1f-9de0-cc7227c63768
Pharmacologic class: Estrogen Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N425021047174 followed by a unit qualifier and the quantity

Package 25021-0471-74. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 211422

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211422
Product	Strength	Form · route	Labeler	Product NDC
Fulvestrant	Fulvestrant 50 mg/mL	Injection, SolutionIntramuscular	Avenacy, Inc.	83634-203
Fulvestrant	Fulvestrant 50 mg/mL	Injection, SolutionIntramuscular	Athenex Pharmaceutical Division, LLC.	70860-211
Fulvestrant	Fulvestrant 50 mg/mL	InjectionIntramuscular	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	71731-6121